✦ LIBER ✦

3546 POSTER (XELOX)Capecitabine plus Oxaliplatin: clinical efficacy and safety in first-line treatment for metastatic gastric cancer

✍ Scribed by M. Alu'; A. Laudani; V. Leonardi; V. Palmisano; G. Savio; A. Pepe; C. Arcuri; M.P. Cusimano; C. Calabria; B. Agostara

Book ID: 118625891
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 58 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(07)71049-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF

Biweekly XELOX (capecitabine and oxalipl

Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer

✍ Grande, Carlos; Quintero, Guillermo; Candamio, Sonia; París Bouzas, Lorena; Vill 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 337 KB

Phase II study of capecitabine plus oxal

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

669 PUBLICATION Capecitabine and oxalipl

669 PUBLICATION Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced / metastatic colorectal cancer (MCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

636 POSTER Initial safety findings from

636 POSTER Initial safety findings from a phase III study of capecitabine (X) plus oxaliplatin (XELOX) vs. infusional 5-FU/LV plus oxaliplatin (FOLFOX-6) in first-line treatment of patients (pts) with metastatic colorectal cancer (MCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 258 KB

703 PUBLICATION Phase II multicenter stu

703 PUBLICATION Phase II multicenter study of capecitabine plus oxaliplatin (XELOX) sequentially followed by capecitabine and irinotecan (XELIRI) in first-line therapy for metastatic colorectal cancer (MCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 267 KB